Tag Archives: drug

Harvard Health Ad Watch: A feel-good message about a diabetes drug

This 60-second advertisement for Trulicity, a medication for diabetes, is one of the most feel-good medication commercials I’ve ever seen. The narrator never uses the scare tactic of so many other ads, listing the terrible things that could happen if you don’t take the treatment. Instead, from start to finish, music, images, and spoken words… Read More »

It has come to this: ignore vaccines-in-animals drug industry PR & news

A long-haired male golden hamster (via Wikipedia & Creative Commons) Earlier this week, a powerful opinion piece, “It Has Come To This:  Ignore the CDC,”  co-authored by former National Institutes of Health director Harold Varmus,  was published in the New York Times. That’s on the science side. On the PR and journalism side, it has… Read More »

FiercePharmaPolitics—Trump’s drug pricing executive orders won’t bring real change: experts

Drug pricing rhetoric has been quieted amid the COVID-19 pandemic and protests over racial justice, but President Donald Trump revived the topic on Friday. With four executive orders, the president pledged to lower prices through several previous policy proposals with months to go until the election. While Trump’s executive orders ran into immediate pushback from the drug industry, they won’t affect pricing all… Read More »

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Pomalyst (pomalidomide) for AIDS-Related and HIV-Negative Kaposi Sarcoma

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–May 15, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Pomalyst ® (pomalidomide) was approved by the U.S. Food and Drug Administration (FDA) for patients with AIDS-related Kaposi sarcoma whose disease has become resistant to highly active antiretroviral therapy (HAART), or in patients with Kaposi sarcoma who are… Read More »

Brain tumors respond well to combo of radiation, schizophrenia drug

By Denise Heady Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors. The findings, published May 1 in Proceedings of the National Academy of Sciences,… Read More »